↑ Rising
Business
Argenx to acquire Unnatural Products in deal worth up to $1.15B
Argenx agrees to acquire Unnatural Products for up to $1.15 billion, betting on AI-guided macrocycle technology to expand oral peptide drug development.
Unnatural Products
1 trends tracked about this subject — the full history, oldest to newest below.